Refine your search

Search Results

Here are the studies that match your search criteria. If you are interested in participating, please reach out to the contact listed for the study. If no contact is listed, contact us and we'll help you find the right person.

1 Study Matches

A Phase 1a/b Trial of CG-806 in Patients with Relapsed/Refractory Acute Myeloid Leukemia or Higher-Risk Myelodysplastic Syndromes

Study of safety and efficacy of CG-806 in patients with previously treated relapsed/refractory AML or Higher-Risk Myelodysplastic Syndromes
Rachael Griffith at rgriffith2@pennstatehealth.psu.edu or 717-531-7128
All
18 year(s) or older
This study is NOT accepting healthy volunteers
NCT04477291
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
AML or high risk MDS whose disease has relapsed, is refractory or who are ineligible for or intolerant of intensive chemotherapy or transplantation
Age ≥18 years.
Life expectancy of at least 3 months.
Exclusion Criteria:
Acute promyelocytic leukemia
Stem cell transplantation within 4 weeks prior to signing the informed consent form.
Pregnant or lactating women.
Cancer
  Email this study information to me
  Contact the study team
  See more information
  Show all 1 locations

Study Locations

Hide all locations
Location
Hershey, PA